Lattice loss reduction

US10758495B2 · kind B2 · utility

Assignee

• Luye Pharma AG · DE

Inventors

• Ludwig Grader · Andernach, DE
• Holger Piotrowski · Weißenthurm, DE

Key dates

• Filing date: Jan 21, 2013
• Grant date: Sep 1, 2020
• Expiry date: Sep 18, 2033

Classification

• Technology area (CPC B): Performing Operations; Transporting
• CPC primary: B23D19/065
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods for producing systems for the transdermal or permucosal administration of active substances and particularly transdermal therapeutic systems (TTS), wherein the active substance depots thereof have a shape that deviates from a rectangular design.